TORONTO, May 11, 2026 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Company”)(TSXV:HFC) today announced the acquisition of a 10% stake in dry bulk shipping company, ICON Energy Corp. (“Icon Energy”)(ICON:NASDAQ) Hampton has acquired a 10% stake in Icon Energy in open market transactions.  The purchases of an aggregate of 325,000 common shares of Icon Energy are for investment purposes.  The total investment by Hampton was approximately C$550,000. Icon Energy is an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. Icon Energy maintains its principal executive office in Athens, Greece, and its common shares trade on the Nasdaq Capital Market under the symbol “ICON.” Icon Energy owns 3 dry bulk vessels...

Enlitic’s Ensight Goes Live at RHCNZEnlitic, a global leader in radiology and imaging data, today announced the successful go-live of its Ensight platform at RHCNZ Medical Imaging Group (RHCNZ), New Zealand’s largest private radiology provider.LOVELAND, Colo., May 11, 2026 (GLOBE NEWSWIRE) — Enlitic, a global leader in radiology and imaging data, today announced the successful go-live of its Ensight platform at RHCNZ Medical Imaging Group (RHCNZ), New Zealand’s largest private radiology provider. The deployment marks Enlitic’s first customer in New Zealand and represents a significant milestone in the company’s continued global expansion. RHCNZ reads more than one in three radiology scans performed in New Zealand and operates more than 65 clinics across the country under the Auckland Radiology, Bay Radiology and Pacific...

Partnership combines venture creation and biologics discovery to accelerate novel medicines through human clinical proof of concept First-of-its-kind collaboration between a specialist biotech venture firm and a publicly-traded biopharma Initial focus on autoimmune diseases using bi- and tri-specific antibody approaches that combine novel and de-risked targets and mechanismsCAMBRIDGE, Mass. and TAIPEI, Taiwan, May 11, 2026 (GLOBE NEWSWIRE) — Delos Capital (“Delos”) and AP Biosciences, Inc. (“APBio”), today announced a strategic collaboration to create and incubate new biotechnology companies. The parties’ initial focus is the discovery and development of novel immune-related drug candidates through early clinical proof of concept. The model leverages Delos’ track record in building and leading biotech companies with APBio’s...

Minneapolis, MN, May 11, 2026 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced a new $300 million receivables funding facility with Mesirow Alternative Credit (f.k.a. Bastion), which will serve as both Lender and Administrative Agent. The new facility doubles the Company’s original $150 million committed facility established in April 2024, which was subsequently expanded to $225 million through an accordion feature. The refinancing lowers Sezzle’s cost of capital and expands committed capacity to support the Company’s continued growth.   The facility carries an interest rate of Secured Overnight Financing Rate (SOFR) plus 3.86%, a reduction of nearly 290 basis points from the prior facility’s spread of 6.75%. The advance rate has been increased...

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Terra Rossa Gold Ltd. (TSXV:TRR) (OTCQB:TRGXF), (“Terra Rossa” or the “Company”)   is pleased to announce it has granted an aggregate of 3,350,000 stock options (the “Options”) to directors, officers, and consultants of the Company to purchase 3,350,000 common shares (the “Shares”) in the capital of the Company pursuant to the Company’s share option plan (the “Option Grant”). The Options will have a one-year vesting period and are exercisable at an exercise price of $0.50 per Share for a period of five years from the date of grant. About Terra Rossa Gold Ltd. The Company is a gold exploration and development corporation with an experienced mine development team. A local exploration and administration team is in place in Colombia, and the Company also has a local community...

CALGARY, Alberta, May 11, 2026 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger” or the “Company”) (TSX: BDGI) announced today the appointment of Logan Mellott as Chief Operating Officer, effective immediately. Prior to this appointment, Mr. Mellott served as Senior Vice President, Operations, Strategic Initiatives and Fleet. Mr. Mellott is a revenue-driven executive known for scaling high-performing teams, aligning sales and operations, and delivering measurable results across complex, asset-heavy industries. In his new role, Mr. Mellott will oversee Badger’s day-to-day operations, drive strategic execution, and further advance the Company’s commitments to safety, operational efficiency, and an exceptional customer experience – all in support of Badger’s long-term...

Toronto, Ontario, Canada, May 11, 2026 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company” or “Canada Carbon“) (TSX-V:CCB) (FF:U7N1) — Canada Carbon announces that the Ontario Securities Commission (the “OSC”) has issued a failure-to-file cease trade order (the “FFCTO“) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions against the Company as a result of the Company’s failure to file its: (i) audited consolidated financial statements for the year ended December 31, 2025 (the “Annual Financial Statements“), (ii) management’s discussion and analysis relating to the Annual Financial Statements, and (iii) CEO and CFO certificates relating to the Annual Financial Statements (collectively, the “Annual Filings“)....

•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, today announced that they had entered into a definitive agreement in which MacroGenics will sell its good manufacturing practice (GMP) drug substance manufacturing operations to Bora, subject to customary closing conditions. “When MacroGenics articulated its strategic priorities last year, we committed to building a more focused company...

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the first quarter of 2026 by conference call on Friday, May 15, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference by navigating to: https://dpregister.com/sreg/10209272/104069d5d88. Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730....

Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary(1)Net revenue increased 19% to $27.8 million, compared to $23.4 million in the first quarter of 2025. Gross profit of $25.9 million, or 93% of net revenue, compared to gross profit of $21.6 million, or 92% of net revenue, in the first quarter of 2025. Operating...